Asahi Kasei Corporation (TYO:3407)
1,472.50
-66.00 (-4.29%)
Nov 20, 2026, 3:30 PM JST
Asahi Kasei Employees
Asahi Kasei had 47,895 employees as of March 31, 2026. The number of employees decreased by 2,457 or 4.88% compared to the previous year. That makes Asahi Kasei the 748th largest employer in the world and 66th in Japan.
Employees
47,895
Change (1Y)
-2,457
Growth (1Y)
-4.88%
Revenue / Employee
68.44M JPY
Profits / Employee
4.07M JPY
Market Cap
1.96T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 47,895 | -2,457 | -4.88% |
| Mar 31, 2025 | 50,352 | 1,057 | 2.14% |
| Mar 31, 2024 | 49,295 | 398 | 0.81% |
| Mar 31, 2023 | 48,897 | 2,146 | 4.59% |
| Mar 31, 2022 | 46,751 | 2,254 | 5.07% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Toyota Tsusho | 74,927 |
| Kyocera | 73,856 |
| FUJIFILM Holdings | 73,526 |
| AGC Inc. | 52,896 |
| Kintetsu Group Holdings | 44,759 |
| Kawasaki Heavy Industries | 39,689 |
| Sojitz | 26,789 |
| Hankyu Hanshin Holdings | 23,867 |
Asahi Kasei News
- 10 days ago - Asahi Kasei, Circularise, and Furuya Metal Launch Demonstration Project for Precious Metal Traceability in Chlor-Alkali Electrolysis Electrodes - Business Wire
- 17 days ago - Asahi Kasei H1 Profit Climbs, Lifts FY26 Outlook - Nasdaq
- 17 days ago - Asahi Kasei Quarterly report: Q2 2027 - Filings
- 17 days ago - Asahi Kasei Slides: Q2 2027 - Filings
- 18 days ago - Asahi Kasei Signs MOU With Power to Hydrogen to Accelerate Commercialization of AEM Water Electrolysis for Clean Hydrogen Production - Business Wire
- 6 weeks ago - Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults - Business Wire
- 6 weeks ago - US FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
- 6 weeks ago - Asahi Kasei Microdevices Holds IEEE Milestone Commemoration Ceremony in Nobeoka for the Commercialization of Thin-Film Hall Elements - Business Wire